The Journal of Experimental Medicine
StemCell Technologies
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ross, V.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ross, V.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
The Journal of Experimental Medicine, Vol 55, 1-12, Copyright, 1932, by The Rockefeller Institute for Medical Research New York

ARTICLE

THE RÔLE OF THE SOLUBLE SPECIFIC SUBSTANCE IN ORAL IMMUNIZATION AGAINST PNEUMOCOCCUS TYPES II AND III

Victor Ross Ph.D.1

1 From the Bureau of Laboratories, Department of Health of the City of New York, New York

1. When the soluble specific substance of Type II pneumococcus was fed to rats, little or no increased resistance to the organism was obtained.

2. When the specific substance of Type III pneumococcus was fed, an increased resistance to the virulent organism resulted. The percentage of animals protected is smaller than when the whole or the dissolved cell is fed.

3. When the specific polysaccharide of Type I was fed, no immunity against Type II or III was obtained, and the ingestion of the specific substances of Types II and III did not protect rats against the Type I organism.

 Submitted on July 28, 1931


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS